COVID-19 can substantially alter nearly every line on a standard complete blood count, and the pattern of those changes often tracks with how sick a person is. The most consistent finding across studies is a drop in lymphocytes paired with a rise in neutrophils, but platelet counts, red blood cell markers, and even less commonly watched cell lines shift too. Understanding which numbers move and what those movements mean gives you practical context for reading your own lab work during or after an infection.
The White Blood Cell Shift
The hallmark CBC change in COVID-19 is lymphopenia, a drop in lymphocytes. These are the immune cells most directly involved in fighting viral infections, and SARS-CoV-2 drives their numbers down through several routes: the virus can infect certain lymphocytes directly, the massive inflammatory response pushes them out of the bloodstream and into damaged lung tissue, and signaling molecules released during the infection can trigger their premature death. A narrative review of the literature found that decreased lymphocyte counts, along with decreased eosinophil and basophil counts, were consistently associated with COVID-19 infection and worse outcomes.1PubMed Central. Complete blood count alterations in COVID-19 patients: A narrative review
One study of hospitalized COVID-19 patients found that roughly 44% had lymphopenia on admission. Older patients were more likely to arrive with low counts, and the presence of lymphopenia correlated with worse lung imaging, weaker oxygen levels, and signs of liver and kidney stress.2Archives of Medical Science. Reduction of lymphocyte count at early stage elevates severity and death risk of COVID-19 patients: a hospital-based case-cohort study Among the patients with lymphopenia in that study, about a third died, a fatality rate far higher than in patients whose lymphocyte counts stayed normal.
What makes the lymphocyte trend especially informative is how it moves over time. A retrospective cohort study tracked daily lymphocyte counts and found that in patients who survived, lymphocyte numbers climbed back up during the first ten days of hospitalization, while in those who died, counts continued to fall. The gap between the two groups widened by an average of roughly 0.07 × 10⁹/L per day.3PubMed Central. Early decrease in blood lymphocyte count is associated with poor prognosis in COVID-19 patients: a retrospective cohort study In other words, the direction a lymphocyte count was heading mattered at least as much as the number on any single day.
While lymphocytes drop, neutrophils typically rise. Neutrophils are the immune system’s first-responder cells, and the intense inflammation COVID triggers recruits them in large numbers. A study from Makkah found significant increases in white blood cell counts overall, driven by neutrophil surges, in patients with severe disease and in those who did not survive.4PubMed Central. Complete blood cells count abnormalities in COVID-19 patients and their prognostic significance: Single center study in Makkah, Saudi Arabia This combination of lymphocytes going down and neutrophils going up creates a signature ratio that clinicians have relied on heavily.
Why Doctors Pay Attention to the Neutrophil-to-Lymphocyte Ratio
The neutrophil-to-lymphocyte ratio, or NLR, became one of the most studied bedside indicators during the pandemic. It captures two movements in a single number: rising neutrophils (indicating intense inflammation) and falling lymphocytes (indicating immune suppression). In healthy people the ratio hovers in the low single digits. In severe COVID it can climb dramatically.
A large systematic review and meta-analysis found that each one-unit increase in NLR was associated with roughly sixfold higher odds of severe disease and more than twelvefold higher odds of death.5PubMed Central. Prognostic value of neutrophil‐to‐lymphocyte ratio in COVID‐19 patients: A systematic review and meta‐analysis A separate meta-analysis confirmed the pattern: severe cases and non-survivors consistently had higher NLR values on admission, and patients with elevated NLR had roughly two to three times the mortality risk regardless of which cutoff value was used.6PubMed Central. Neutrophil-to-lymphocyte ratio on admission to predict the severity and mortality of COVID-19 patients: A meta-analysis
Researchers also looked at whether tracking NLR over time added value beyond a single admission snapshot. A retrospective cohort study found that both NLR and the platelet-to-lymphocyte ratio were higher in patients with severe COVID at every time point measured, and that serial NLR values could reasonably distinguish severe from non-severe cases throughout a hospital stay.7PubMed Central. Dynamic NLR and PLR in Predicting COVID-19 Severity: A Retrospective Cohort Study The practical takeaway is that NLR is not just a one-time warning flag. A ratio that keeps climbing after admission carries a worse signal than one that stabilizes or falls.
What Happens to Platelets
Platelet counts often drop during COVID-19, though the pattern is more complex than a simple decline. In mild cases, platelet numbers may stay within the normal range or even temporarily rise as part of the acute-phase inflammatory response. In severe disease, however, platelet counts tend to fall. A study of hospitalized patients found a significant decrease in platelets among clinically severe cases and among those who died.4PubMed Central. Complete blood cells count abnormalities in COVID-19 patients and their prognostic significance: Single center study in Makkah, Saudi Arabia
Even when the platelet count looks normal on a CBC printout, the platelets themselves may not be behaving normally. Research has shown that COVID-19 platelets are hyperreactive, meaning they clump together more easily and display surface proteins associated with clot formation. Their gene-expression profile shifts toward a pattern characteristic of large, immature platelets with strong clotting potential.8PubMed Central. Platelets contribute to disease severity in COVID-19 This helps explain why COVID-19 carried a high rate of blood clots even in patients whose platelet count on paper seemed acceptable. A standard CBC reports platelet quantity, not platelet behavior, so the number alone could understate the clotting risk.
In some patients, the immune system mounts an attack against its own platelets, a condition called immune thrombocytopenia. A systematic review found that COVID-associated immune thrombocytopenia was a recognized complication, with pooled data showing significant platelet drops in the affected cases.9PubMed Central. COVID-19 associated with immune thrombocytopenia: a systematic review and meta-analysis This kind of platelet crash can look alarming on a CBC and sometimes requires its own treatment, separate from COVID management.
Red Blood Cell Changes and the RDW Signal
Red blood cell parameters on a CBC get less attention than white cells in COVID conversations, but they shift too. Non-survivors of COVID-19 tend to have lower hemoglobin levels and lower hematocrit compared with survivors.10PubMed Central. Back to Basics: The Diagnostic Value of a Complete Blood Count in the Clinical Management of COVID-19 The anemia is usually mild and doesn’t tend to be the dominant clinical problem, but it adds to the picture.
A more telling marker turned out to be the red cell distribution width, or RDW, which measures how much variation exists in the size of your red blood cells. A higher RDW suggests that the bone marrow is stressed or that red cell turnover is disrupted. In a large study of hospitalized COVID patients, those with an RDW above 14.5% at admission had a 31% mortality rate compared with 11% in patients whose RDW was at or below that threshold.11JAMA Network Open. Association of Red Blood Cell Distribution Width With Mortality Risk in Hospitalized Adults With SARS-CoV-2 Infection That is a nearly threefold difference in death rates, based on a number that is printed on every standard CBC but that many patients (and some clinicians) skip right over.
Follow-up research has shown that factoring RDW into existing severity-scoring systems improves their accuracy. In a cohort of over 3,200 non-critical hospitalized COVID patients, about one in five had an elevated RDW on admission, and accounting for that value meaningfully changed the risk prediction within established scoring tools.12PubMed Central. Accounting for Red Cell Distribution Width Improves Risk Stratification by Commonly Used Mortality/Deterioration Risk Scores in Adult Patients Hospitalized Due to COVID-19
Eosinophils and the Cells Nobody Talks About
Most discussions about COVID and blood counts focus on lymphocytes, neutrophils, and platelets, but smaller cell populations shift too. Eosinophils, white blood cells typically associated with allergies and parasitic infections, tend to drop during COVID and the depth of that drop has prognostic meaning. A retrospective study of ICU patients found that those with very low eosinophil counts were significantly more likely to die. The researchers identified a cutoff below which outcomes were markedly worse, and patients falling under that line had substantially higher fatality rates.13PubMed Central. Predictive Value of Eosinophil Count on COVID-19 Disease Progression and Outcomes, a Retrospective Study of Leishenshan Hospital in Wuhan, China
Beyond the numbers a CBC prints, the appearance of blood cells under a microscope also changes. A study examining blood smears from COVID patients found that smudge cells (fragile white cells that break apart on the slide) were the most common abnormality. Other findings included fragmented red blood cells, atypical lymphocytes, a leftward shift in granulocyte maturity suggesting the bone marrow was releasing younger cells than usual, and unusually large platelets.14PubMed Central. Blood cell morphology and COVID-19 clinical course, severity, and outcome Most of these findings won’t show up on a standard automated CBC report, but they illustrate how deeply the virus disrupts normal blood cell biology.
How COVID-19 Affects the Bone Marrow Itself
Many of the CBC changes during COVID trace back to what the virus does to the bone marrow, the factory where blood cells are produced. SARS-CoV-2 infection is associated with a range of bone marrow disruptions, including reduced production of one or more cell lines, hemophagocytosis (immune cells eating other blood cells), and in severe cases, actual marrow tissue death.15PubMed. Bone marrow alterations in COVID-19 infection: The root of hematological problems The causes are layered: the massive release of inflammatory signaling molecules batters the marrow’s normal function, the virus may directly damage marrow cells through various receptors, and treatments like corticosteroids can themselves suppress blood cell production.
This marrow-level disruption is important context for understanding why CBC abnormalities sometimes last well beyond the acute infection. The marrow doesn’t snap back to full function the moment viral replication stops, which sets the stage for lingering lab abnormalities during recovery.
How Long CBC Changes Last After Recovery
If you catch COVID and your blood counts shift, you might reasonably wonder how long those changes stick around. The answer varies by cell type and by how sick you were. A follow-up study of patients who had recovered from COVID found that about 12% still had lymphopenia at a median of 70 days after infection. Even at the later follow-up window of 80 to 102 days out, roughly 14% of the patients tested still had lymphocyte counts below normal.16Scientific Reports. Persistent symptoms and lab abnormalities in patients who recovered from COVID-19
In the context of long COVID, hematological changes can persist for months. A review of the literature found sustained alterations in red blood cells, ongoing lymphopenia, and elevated inflammatory markers like ferritin and D-dimer in people with prolonged symptoms.17PubMed Central. Hematological alterations associated with long COVID-19 A cross-sectional study comparing patients with and without chronic symptoms at six months found that NLR remained significantly higher in the group still experiencing symptoms, even when other CBC parameters had normalized.18PubMed Central. Correlations of Long COVID Symptoms and Inflammatory Markers of Complete Blood Count (CBC): A Cross-sectional Study So if you’re months out from COVID and your doctor orders a CBC, don’t be surprised if some values are still slightly off.
How COVID CBC Changes Compare to Influenza
One practical question many people have is whether a CBC alone can tell you whether you have COVID versus another respiratory infection like the flu. The two illnesses share some overlapping blood count features, but there are distinctions. A retrospective comparison found that patients with influenza were more likely to have a white blood cell count above 9,000/μL, while COVID patients tended to have white counts that were normal or even low.19PubMed Central. Comparison of the clinical parameters of patients with COVID-19 and influenza using blood test data: a retrospective cross-sectional survey COVID patients were more likely to present with fatigue and respiratory symptoms, while flu patients more often had higher fevers and nausea.
A separate study reached a similar finding: elevated white blood cell counts were more characteristic of flu, while COVID patients more often showed the distinctive lymphopenia pattern.20Pakistan Journal of Medical and Health Sciences. Evaluation of the Clinical Parameters of Patients with Influenza and Covid-19 using Blood Test Data None of this is reliable enough to diagnose one infection over the other from blood work alone, but the CBC pattern can add useful context when interpreted alongside symptoms and testing.
Did Different Variants Cause Different CBC Patterns?
As the virus evolved through Alpha, Delta, Omicron, and other variants, researchers asked whether the blood count signature changed too. The answer is nuanced. A study comparing Delta and Omicron patients found no statistically significant differences in most standard CBC indices, including white blood cell counts, hemoglobin, and lymphocyte levels.21PubMed Central. Lab results of COVID-19 patients: Omicron vs delta variants Neutrophil counts were slightly above normal for both variants, without a meaningful difference between them.
A different study comparing the two variants found that the relationship between CBC values and death differed somewhat: in the Delta wave, multiple cell counts on admission were significantly associated with mortality, while in the Omicron wave, fewer parameters reached statistical significance.22PubMed Central. Retrospective Observational Study of Complete Blood Count (CBC) Parameters and ICU Mortality of COVID-19 Disease in Delta Variant and Omicron Variant in a Community-Based Hospital in New York City A broader comparison across Alpha, Delta, and Omicron found that while the overall pattern of CBC disruption stayed recognizable, specific parameters like white blood cell count, platelet count, and neutrophil percentage did show significant differences between variant groups.23PubMed Central. Variant-Related Differences in Laboratory Biomarkers among Patients Affected with Alpha, Delta and Omicron: A Retrospective Whole Viral Genome Sequencing and Hospital-Setting Cohort Study The basic story held across variants, but the intensity varied.
How COVID Treatments Change the CBC Picture
If you’re looking at a CBC taken during a COVID hospitalization, keep in mind that the treatments themselves alter blood counts. Corticosteroids like dexamethasone, which became standard therapy for moderate-to-severe COVID, are well known to push white blood cell counts upward, largely by increasing neutrophils. One study found that patients receiving both dexamethasone and tocilizumab (an anti-inflammatory drug) had significantly higher white blood cell and neutrophil counts compared to patients who received neither medication.24PubMed Central. Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease
This means a CBC drawn mid-treatment can be tricky to interpret. A rising neutrophil count might reflect worsening disease, or it might be a predictable drug effect. An improving lymphocyte count might signal genuine recovery, or it might be masked by the immunosuppressive effects of steroids. Clinicians generally interpret mid-treatment CBC trends in the context of what drugs the patient is receiving, but if you’re looking at your own results without that knowledge, the numbers can be misleading.
Even COVID vaccination produces transient CBC changes, as the immune activation process temporarily shifts white blood cell counts.25Exploratory Research in Clinical and Social Pharmacy. Impact of mRNA COVID-19 vaccination on hematological parameters in patients maintained on clozapine: A retrospective study from Qatar These shifts are generally mild and short-lived, but if you happen to get blood work within a few days of a vaccine dose, the numbers may not reflect your true baseline.
Children and Multisystem Inflammatory Syndrome
Children who contract COVID typically have milder acute blood count changes than adults, but there is an important exception. Multisystem inflammatory syndrome in children, or MIS-C, is a delayed inflammatory reaction that can develop weeks after a COVID infection. The condition comes with its own CBC signature: many affected children have low platelet counts and low absolute lymphocyte counts, alongside elevated markers of inflammation and cardiac stress.26Centers for Disease Control and Prevention. Clinical Overview of Multisystem Inflammatory Syndrome in Children
MIS-C is relatively rare, but the CBC findings help pediatricians distinguish it from other childhood illnesses that cause fever and rash. The combination of thrombocytopenia and lymphopenia in a child with a recent COVID exposure is a red flag that prompts further workup. Parents who see abnormal CBC results in this context should understand that the condition is treatable when caught early and that most children recover fully with appropriate care.
When a Pre-Existing Blood Condition Complicates the Picture
People who already have abnormal blood counts before getting COVID face a double challenge: the infection shifts their numbers further, and the baseline abnormality makes it harder to interpret what COVID is doing. One case report described a patient who, after recovering from COVID, presented with a remarkable drop in hemoglobin and platelets relative to values recorded at the time of discharge. Further investigation revealed acute leukemia with severe bone marrow involvement.27PubMed Central. A Case of Acute Leukemia Following Remission of COVID-19 Infection; an Urge to Search for a Probable Association Whether COVID played a causal role in triggering the leukemia or simply preceded it by coincidence is unclear, but the case highlights an important principle: unexplained or worsening CBC abnormalities after COVID recovery deserve their own diagnostic workup rather than being automatically attributed to the virus.
Patients with sickle cell disease, thalassemia, chronic kidney disease, or other conditions that affect baseline blood counts should be especially attentive to how their numbers change during and after COVID. The infection-related shifts layer on top of their existing abnormalities, and what looks like a modest dip in one cell line for a healthy person might represent a clinically meaningful change for someone whose counts are already compromised.